ARCHIVES

NCI Bypass Budget Seeks $3.64 Billion

This article is from The Cancer Letter archive.

Vol. 21 No. 03 | January 20, 1995

Download PDF Visit The Full Archive

Related Articles

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Science Policy: Silicone Breast Implants Don’t Cause Disease

June 25, 1999

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

Funding Opportunities

September 27, 2002

Program Announcements

July 25, 1986